Skip to main content
DHPC Letter-Levemir® InnoLet® 100 units/ml solution for injection in pre-filled pen & Insulatard® InnoLet® 100 international units/ml suspension for injection in pre-filled pen -UK Discontinuation
For Healthcare Professionals
Novo Nordisk UK in agreement with the Medicines and Healthcare Products Regulatory Agency (MHRA) and the
Department of Health and Social Care (DHSC) would like to inform you of the following:Novo Nordisk has decided to discontinue InnoLet (an injectable device for insulin delivery).
